Vergoeding 2015-2019 voor ATC-subgroep J05AG : Niet-nucleoside reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| J05AG01 Nevirapine (Viramune ®) | 7.061.800 | 6.306.700 | 4.919.000 | 2.800.500 | 1.755.400 |
| J05AG03 Efavirenz (Stocrin ®) | 1.039.900 | 787.280 | 618.070 | 514.910 | 424.280 |
| J05AG04 Etravirine (Intelence ®) | 1.115.500 | 1.052.000 | 856.580 | 720.070 | 595.730 |
| J05AG05 Rilpivirine (Edurant ®) | 277.320 | 254.600 | 290.040 | 313.950 | 295.630 |
| J05AG06 Doravirine (Pifeltro ®) | . | . | . | . | 12.972 |
| Totaal | 9.494.520 | 8.400.580 | 6.683.690 | 4.349.430 | 3.084.012 |